MedPath

Dopamine

Generic Name
Dopamine
Drug Type
Small Molecule
Chemical Formula
C8H11NO2
CAS Number
51-61-6
Unique Ingredient Identifier
VTD58H1Z2X

Overview

One of the catecholamine neurotransmitters in the brain. It is derived from tyrosine and is the precursor to norepinephrine and epinephrine. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (receptors, dopamine) mediate its action.

Background

One of the catecholamine neurotransmitters in the brain. It is derived from tyrosine and is the precursor to norepinephrine and epinephrine. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (receptors, dopamine) mediate its action.

Indication

For the correction of hemodynamic imbalances present in the shock syndrome due to myocardial infarction, trauma, endotoxic septicemia, open-heart surgery, renal failure, and chronic cardiac decompensation as in congestive failure

Associated Conditions

  • Arrhythmia
  • Circulatory collapse and shock
  • Hypotension caused by Trauma, endotoxic septicemia, Open-heart Surgery, Renal Failure, chronic cardiac decompensation, Myocardial Infarction
  • Urine flow decreased caused by Trauma, endotoxic septicemia, Open-heart Surgery, Renal Failure, chronic cardiac decompensation, Myocardial Infarction
  • Decreased cardiac output caused by Trauma, endotoxic septicemia, Open-heart Surgery, Renal Failure, chronic cardiac decompensation, Myocardial Infarction

FDA Approved Products

DOPAMINE HYDROCHLORIDE
Manufacturer:HF Acquisition Co LLC, DBA HealthFirst
Route:INTRAVENOUS
Strength:1.6 mg in 1 mL
Approved: 2024/01/29
NDC:51662-1316
Dopamine Hydrochloride and Dextrose
Manufacturer:Baxter Healthcare Corporation
Route:INTRAVENOUS
Strength:160 mg in 100 mL
Approved: 2017/07/14
NDC:0338-1007
DOPamine Hydrochloride
Manufacturer:Hospira, Inc.
Route:INTRAVENOUS
Strength:40 mg in 1 mL
Approved: 2023/09/21
NDC:0409-5820
DOPAMINE HCI
Manufacturer:HF Acquisition Co. LLC, DBA Health First
Route:INTRAVENOUS
Strength:40 mg in 1 mL
Approved: 2024/02/22
NDC:51662-1220
Dopamine Hydrochloride
Manufacturer:Hikma Pharmaceuticals USA Inc.
Route:INTRAVENOUS
Strength:80 mg in 1 mL
Approved: 2022/05/06
NDC:0143-9253

Singapore Approved Products

TROPIN 200 INJECTION 200 mg/5 ml
Manufacturer:HANLIM PHARMACEUTICAL CO LTD
Form:INJECTION
Strength:200 mg/5 ml
Online:Yes
Approved: 1999/11/04
Approval:SIN11216P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath